News and events
Press Release 07/07/10
TcLand Expression signs a licensing agreement with Inserm Transfert and initiates a strategic collaboration on the development of companion diagnostic tests for rheumatoid arthritis therapies.
Download English |
Download French
Press Release 29/06/10
TcLand Expression initiates major partnership with the Hospital Vall d'Hebron Research Institute and gets exclusive rights on key intellectual property in the field of novel biomarkers in rheumatoid arthritis.
Download English |
Download French
Press Release 17/06/10
TcLand Expression appoints personalized medicine pioneer Patrick Terry as Chairman of the Board of Directors.
Download English |
Download French
Press Release 03/06/10
TcLand Expression strengthen its management team by recruiting Elodie Kazek as VP Marketing and Commercial Operations.
Download English |
Download French
Press Release 27/05/10
TcLand Expression and its collaborative partners receive €450,000 in funding from the French National Research Agency for the company's companion diagnostic program in rheumatoid arthritis.
Download English |
Download French
Press Release 18/05/10
TcLand Expression signs a collaboration agreement with the Hospices Civils de Lyon hospital group for the development of novel biomarkers in rheumatoid arthritis.
Download English |
Download French
Press Release 27/04/10
TcLand Expression’s Liver graft Tolerance eXpression (L-TolX) invitro molecular diagnostic blood test interim clinical data to be presented at the American Transplant Congress (ATC) in San Diego, from May 1st to 5th, 2010.
Download English |
Download French
Press Release 15/04/10
TcLand Expression, a global leader in the field of gene expression biomarkers and companion diagnostics in immunology, today announced that it had achieved ISO 13485:2003 compliance of its quality management system and renewal of its existing ISO 17025:2005 accreditation.
Download English |
Download French
Press Release 13/10/09
TcLand Expression, a global leader in the field of gene expression biomarkers in immunology, launches an international, multicenter clinical validation study on its K-RejX diagnostic blood test for the identification of kidney transplant recipients at risk of chronic rejection.
Download English |
Download French
Press Release 28/04/09
TcLand Expression, a world leader in the field of gene expression biomarkers in immunology, receives €1.8 million in innovation support from Oseo.
Download English |
Download French
Press Release 09/04/09
TcLand Expression, Leader in gene expression biomarkers in immunology, strengthens its Board of Directors. Nomination of Mr Patrick F. Terry as new Board Member.
Download English |
Download French
Press release 24/03/09
Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure for Pioneering Work in Personalized Medicine.
Download English |
Download French
Press Release 10/03/09
TcLand Expression obtains ISO 17025:2005 accreditation for its gene expression assays.
Download English
Press Release 06/02/09
TcLand Expression, leader dans le développement de biomarqueurs d’expression génique, accueille Madame Bachelot-Narquin, Ministre de la Santé et des Sports.
Download French
Press Release 12/09/08
TcLand Expression, Leader in gene expression biomarkers in immunology, strengthens its management team.
Download English |
Download French
Press Release 08/07/08
TcLand Expression & Hospital Clinic - IDIBAPS sign an exclusive licence and collaboration agreement for the development of gene expression biomarker in liver transplantation.
Download English
Press Release 28/05/08
TcLand Expression, a biotechnology company leader in the development of gene expression biomarkers, strengthens management team to accelerate its development.
Download English
Press Release 15/01/08
TcLand Expression SA and its partners, Nantes’ University Hospital, Atlanstat, and Nantes' "GIS Ouest Genopole" transcriptomics platform, today announced the creation of CIMNA, a unique integrated immunomonitoring service platform located in Nantes.
Download French
Press Release 14/12/07
TcLand Expression raises €8.2 million in a Series A round led by Auriga Partners.
Download English
Press Release 10/12/07
TcLand SA announces a company split into two autonomous branches of activity.
Download English
La Tribune 22/01/07
TcLand a posé des remparts tout autour de ses brevets.
Download French
L'Expansion 20/01/07
Greffes: le risque de rejet anticipé.
Download French
Press Release 29/08/06
TcLand strengthens its management team and Board of Directors.
Download English
Press Release 22/05/06
Debiopharm and Tcland sign R&D and exclusive licence option for the development of sc28AT in autoimmune diseases and transplantation.
Download English
Press Release 15/06/05
Inserm-Transfert invests in TcLand.
Download English